Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.510
-0.070 (-4.43%)
Apr 2, 2026, 11:52 AM EDT - Market open
Genprex Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Genprex in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Genprex.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +33,012.58% | May 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +33,012.58% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +33,012.58% | Apr 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +33,012.58% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $500 | Strong Buy | Initiates | $500 | +33,012.58% | Mar 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.17
from -17.40
EPS Next Year
n/a
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | n/a |
| Avg | n/a |
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -1.21 |
| Avg | -1.17 |
| Low | -1.13 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.